L3VLUP
ProSign in
← Two Sigma Advisers LP, latest filing

What Two Sigma Advisers LP changed, 2013 to 2026

53 quarterly 13F filings, from Q2 2013 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.

Reported book

$0

$7.0bn at Q2 2013

Positions

0

2,136 at Q2 2013

Top ten weight

n.a.

19% at Q2 2013

Typical quarterly turnover

about 26%

Estimated from share changes

Reported book by quarter
$0$26bn$51bnQ2 2013: $7.0bnQ3 2013: $8.4bnQ4 2013: $10.4bnQ1 2014: $11.0bn14Q2 2014: $12.8bnQ3 2014: $13.3bnQ4 2014: $12.9bnQ1 2015: $13.6bn15Q2 2015: $13.4bnQ3 2015: $15.9bnQ4 2015: $16.8bnQ1 2016: $17.9bn16Q2 2016: $19.7bnQ3 2016: $23.5bnQ4 2016: $26.1bnQ1 2017: $30.5bn17Q2 2017: $30.3bnQ3 2017: $35.3bnQ4 2017: $37.1bnQ1 2018: $36.9bn18Q2 2018: $37.2bnQ3 2018: $41.0bnQ4 2018: $36.6bnQ1 2019: $39.7bn19Q2 2019: $40.2bnQ3 2019: $40.9bnQ4 2019: $43.1bnQ1 2020: $26.1bn20Q2 2020: $34.0bnQ3 2020: $35.0bnQ4 2020: $37.4bnQ1 2021: $36.4bn21Q2 2021: $37.9bnQ3 2021: $38.6bnQ4 2021: $39.9bnQ1 2022: $37.6bn22Q2 2022: $35.3bnQ3 2022: $34.5bnQ4 2022: $35.8bnQ1 2023: $38.8bn23Q2 2023: $39.3bnQ3 2023: $39.0bnQ4 2023: $42.7bnQ1 2024: $43.2bn24Q2 2024: $44.8bnQ3 2024: $42.7bnQ4 2024: $43.2bnQ1 2025: $44.4bn25Q2 2025: $48.8bnQ3 2025: $50.0bnQ4 2025: $51.4bnQ1 2026: $026Q2 2026: $0
  • Q2 2013: $7.0bn
  • Q3 2013: $8.4bn
  • Q4 2013: $10.4bn
  • Q1 2014: $11.0bn
  • Q2 2014: $12.8bn
  • Q3 2014: $13.3bn
  • Q4 2014: $12.9bn
  • Q1 2015: $13.6bn
  • Q2 2015: $13.4bn
  • Q3 2015: $15.9bn
  • Q4 2015: $16.8bn
  • Q1 2016: $17.9bn
  • Q2 2016: $19.7bn
  • Q3 2016: $23.5bn
  • Q4 2016: $26.1bn
  • Q1 2017: $30.5bn
  • Q2 2017: $30.3bn
  • Q3 2017: $35.3bn
  • Q4 2017: $37.1bn
  • Q1 2018: $36.9bn
  • Q2 2018: $37.2bn
  • Q3 2018: $41.0bn
  • Q4 2018: $36.6bn
  • Q1 2019: $39.7bn
  • Q2 2019: $40.2bn
  • Q3 2019: $40.9bn
  • Q4 2019: $43.1bn
  • Q1 2020: $26.1bn
  • Q2 2020: $34.0bn
  • Q3 2020: $35.0bn
  • Q4 2020: $37.4bn
  • Q1 2021: $36.4bn
  • Q2 2021: $37.9bn
  • Q3 2021: $38.6bn
  • Q4 2021: $39.9bn
  • Q1 2022: $37.6bn
  • Q2 2022: $35.3bn
  • Q3 2022: $34.5bn
  • Q4 2022: $35.8bn
  • Q1 2023: $38.8bn
  • Q2 2023: $39.3bn
  • Q3 2023: $39.0bn
  • Q4 2023: $42.7bn
  • Q1 2024: $43.2bn
  • Q2 2024: $44.8bn
  • Q3 2024: $42.7bn
  • Q4 2024: $43.2bn
  • Q1 2025: $44.4bn
  • Q2 2025: $48.8bn
  • Q3 2025: $50.0bn
  • Q4 2025: $51.4bn
  • Q1 2026: $0
  • Q2 2026: $0
Share of the book in the ten largest positions
0%10%20%Q2 2013: 19%Q3 2013: 14%Q4 2013: 14%Q1 2014: 13%14Q2 2014: 13%Q3 2014: 10%Q4 2014: 10%Q1 2015: 9%15Q2 2015: 9%Q3 2015: 9%Q4 2015: 10%Q1 2016: 11%16Q2 2016: 12%Q3 2016: 10%Q4 2016: 9%Q1 2017: 9%17Q2 2017: 10%Q3 2017: 10%Q4 2017: 9%Q1 2018: 8%18Q2 2018: 9%Q3 2018: 10%Q4 2018: 10%Q1 2019: 10%19Q2 2019: 11%Q3 2019: 12%Q4 2019: 12%Q1 2020: 12%20Q2 2020: 14%Q3 2020: 13%Q4 2020: 12%Q1 2021: 14%21Q2 2021: 13%Q3 2021: 13%Q4 2021: 13%Q1 2022: 14%22Q2 2022: 13%Q3 2022: 14%Q4 2022: 14%Q1 2023: 12%23Q2 2023: 14%Q3 2023: 16%Q4 2023: 17%Q1 2024: 17%24Q2 2024: 18%Q3 2024: 17%Q4 2024: 20%Q1 2025: 18%25Q2 2025: 19%Q3 2025: 19%Q4 2025: 19%Q1 2026: 0%26Q2 2026: 0%
  • Q2 2013: 19%
  • Q3 2013: 14%
  • Q4 2013: 14%
  • Q1 2014: 13%
  • Q2 2014: 13%
  • Q3 2014: 10%
  • Q4 2014: 10%
  • Q1 2015: 9%
  • Q2 2015: 9%
  • Q3 2015: 9%
  • Q4 2015: 10%
  • Q1 2016: 11%
  • Q2 2016: 12%
  • Q3 2016: 10%
  • Q4 2016: 9%
  • Q1 2017: 9%
  • Q2 2017: 10%
  • Q3 2017: 10%
  • Q4 2017: 9%
  • Q1 2018: 8%
  • Q2 2018: 9%
  • Q3 2018: 10%
  • Q4 2018: 10%
  • Q1 2019: 10%
  • Q2 2019: 11%
  • Q3 2019: 12%
  • Q4 2019: 12%
  • Q1 2020: 12%
  • Q2 2020: 14%
  • Q3 2020: 13%
  • Q4 2020: 12%
  • Q1 2021: 14%
  • Q2 2021: 13%
  • Q3 2021: 13%
  • Q4 2021: 13%
  • Q1 2022: 14%
  • Q2 2022: 13%
  • Q3 2022: 14%
  • Q4 2022: 14%
  • Q1 2023: 12%
  • Q2 2023: 14%
  • Q3 2023: 16%
  • Q4 2023: 17%
  • Q1 2024: 17%
  • Q2 2024: 18%
  • Q3 2024: 17%
  • Q4 2024: 20%
  • Q1 2025: 18%
  • Q2 2025: 19%
  • Q3 2025: 19%
  • Q4 2025: 19%
  • Q1 2026: 0%
  • Q2 2026: 0%

The positions that defined it

Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.

PositionValue over timeFirst listedLargestQ2 2026
Nvidia Corp(NVDA)Q3 2016$1.7bnQ4 2025Soldlast listed Q4 2025
Apple Inc(AAPL)Q3 2013$1.6bnQ4 2025Soldlast listed Q4 2025
Microsoft Corp(MSFT)Q3 2014$1.5bnQ3 2025Soldlast listed Q4 2025
Amazon Com Inc(AMZN)Q1 2015$1.1bnQ4 2025Soldlast listed Q4 2025
Alphabet Inc(GOOGL)Capital Stock Class AQ4 2015$801mQ2 2025Soldlast listed Q4 2025
JPMorgan Chase & Co(JPM)Q2 2013$769mQ3 2025Soldlast listed Q4 2025
Facebook Inc A(META)Class AQ3 2014$726mQ4 2024Soldlast listed Q4 2025
Mastercard Inc(MA)Class AQ3 2014$701mQ4 2025Soldlast listed Q4 2025

Quarter by quarter

2026Q1Q2
2025Q1Q2Q3Q4
2024Q1Q2Q3Q4
2023Q1Q2Q3Q4
2022Q1Q2Q3Q4
2021Q1Q2Q3Q4
2020Q1Q2Q3Q4
2019Q1Q2Q3Q4
2018Q1Q2Q3Q4
2017Q1Q2Q3Q4
2016Q1Q2Q3Q4
2015Q1Q2Q3Q4
2014Q1Q2Q3Q4
2013Q2Q3Q4

Q4 2021: $39.9bn across 2,591 positions

Against Q3 2021: 504 new, 855 added to, 1,220 trimmed, 327 sold out, across all 2,591 positions.

Turnover about 28% of the book, estimated from share changes at quarter-end prices.

Largest additions

  • Tesla Motors Inc (TSLA)+$400m
  • Pfizer Inc (PFE)+$340m
  • Activision Blizzard Inc+$327m
  • Thermo Fisher Scientific Inc (TMO)+$287m
  • PayPal HLDGS Inc (PYPL)+$272m
  • Abbvie Inc (ABBV)+$242m
  • Dexcom Inc (DXCM)+$234m
  • Datadog Inc (DDOG)+$201m

Largest reductions

  • Qualcomm Inc (QCOM)-$364m
  • Alphabet Inc (GOOGL)-$358m
  • AT&T Inc (T)-$309m
  • Danaher Corp Del (DHR)-$214m
  • Baidu Inc/China (BIDU)-$213m
  • Intuitive Surgical Inc (ISRG)-$202m
  • Abbott Labs (ABT)-$198m
  • Moderna Inc (MRNA)-$174m

Opened

  • Nvidia Corp (NVDA)$370m

Sold out

  • Snap Inc (SNAP)was $379m
  • Analog Devices Inc (ADI)was $283m
  • Ke HLDGS Inc (BEKE)was $115m
  • Accenture PLC Ireland (ACN)was $111m
  • PPD Incwas $59m
  • Hill Rom HLDGS Incwas $57m
  • Bce Inc (BCE)was $45m
  • Cme Group Inc (CME)was $43m

Largest positions, Q4 2021

The largest 25 of 2,591 reported positions; the largest 500 carry 89.4% of the reported value.

PositionValueWeightOn the quarter
Microsoft Corp (MSFT)$930m2.3%Trimmed
Johnson & Johnson (JNJ)$545m1.4%Trimmed
Visa Inc (V)$536m1.3%Added
Apple Inc (AAPL)$521m1.3%Trimmed
Lilly Eli & Co (LLY)$491m1.2%Trimmed
Facebook Inc A (META)$490m1.2%Added
Coca Cola Co (KO)$476m1.2%Added
Medtronic PLC (MDT)$432m1.1%Added
Charter Communications Inc N (CHTR)$425m1.1%Added
Bristol Myers Squibb Co (BMY)$413m1.0%Added
S&P Global Inc (SPGI)$411m1.0%Added
Amgen Inc (AMGN)$407m1.0%Trimmed
Tesla Motors Inc (TSLA)$406m1.0%Added
Zscaler Inc (ZS)$389m1.0%Added
Pfizer Inc (PFE)$383m1.0%Added
Activision Blizzard Inc$373m0.9%Added
Nvidia Corp (NVDA)$370m0.9%New
Merck & Co Inc New (MRK)$360m0.9%Trimmed
Caterpillar Inc Del (CAT)$359m0.9%Trimmed
Atlassian Corp PLC$358m0.9%Added
Boston Scientific Corp (BSX)$356m0.9%Added
Cerner Corp$349m0.9%Added
Datadog Inc (DDOG)$344m0.9%Added
PayPal HLDGS Inc (PYPL)$324m0.8%Added
Etsy Inc (ETSY)$318m0.8%Added

The filings behind it

Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.

QuarterFilerBookAmendedFiling
Q2 2026Two Sigma Advisers LP$013F-HR
Q1 2026Two Sigma Advisers LP$013F-HR
Q4 2025Two Sigma Advisers LP$51.4bn13F-HR
Q3 2025Two Sigma Advisers LP$50.0bn13F-HR
Q2 2025Two Sigma Advisers LP$48.8bn13F-HR
Q1 2025Two Sigma Advisers LP$44.4bn13F-HR
Q4 2024Two Sigma Advisers LP$43.2bn13F-HR
Q3 2024Two Sigma Advisers LP$42.7bn13F-HR
Q2 2024Two Sigma Advisers LP$44.8bn13F-HR
Q1 2024Two Sigma Advisers LP$43.2bn13F-HR
Q4 2023Two Sigma Advisers LP$42.7bn13F-HR
Q3 2023Two Sigma Advisers LP$39.0bn13F-HR
Q2 2023Two Sigma Advisers LP$39.3bn13F-HR
Q1 2023Two Sigma Advisers LP$38.8bn13F-HR
Q4 2022Two Sigma Advisers LP$35.8bn13F-HR
Q3 2022Two Sigma Advisers LP$34.5bn13F-HR
Q2 2022Two Sigma Advisers LP$35.3bn13F-HR
Q1 2022Two Sigma Advisers LP$37.6bn13F-HR
Q4 2021Two Sigma Advisers LP$39.9bn13F-HR
Q3 2021Two Sigma Advisers LP$38.6bn13F-HR
Q2 2021Two Sigma Advisers LP$37.9bn13F-HR
Q1 2021Two Sigma Advisers LP$36.4bn13F-HR
Q4 2020Two Sigma Advisers LP$37.4bn13F-HR
Q3 2020Two Sigma Advisers LP$35.0bn13F-HR
Q2 2020Two Sigma Advisers LP$34.0bn13F-HR
Q1 2020Two Sigma Advisers LP$26.1bn13F-HR
Q4 2019Two Sigma Advisers LP$43.1bn13F-HR
Q3 2019Two Sigma Advisers LP$40.9bn13F-HR
Q2 2019Two Sigma Advisers LP$40.2bn13F-HR
Q1 2019Two Sigma Advisers LP$39.7bn13F-HR
Q4 2018Two Sigma Advisers LP$36.6bn13F-HR
Q3 2018Two Sigma Advisers LP$41.0bn13F-HR
Q2 2018Two Sigma Advisers LP$37.2bn13F-HR
Q1 2018Two Sigma Advisers LP$36.9bn13F-HR
Q4 2017Two Sigma Advisers LP$37.1bn13F-HR
Q3 2017Two Sigma Advisers LP$35.3bn13F-HR
Q2 2017Two Sigma Advisers LP$30.3bn13F-HR
Q1 2017Two Sigma Advisers LP$30.5bn13F-HR
Q4 2016Two Sigma Advisers LP$26.1bn13F-HR
Q3 2016Two Sigma Advisers LP$23.5bn13F-HR
Q2 2016Two Sigma Advisers LP$19.7bn13F-HR
Q1 2016Two Sigma Advisers LP$17.9bn13F-HR
Q4 2015Two Sigma Advisers LP$16.8bn13F-HR
Q3 2015Two Sigma Advisers LP$15.9bn13F-HR
Q2 2015Two Sigma Advisers LP$13.4bn113F-HR
Q1 2015Two Sigma Advisers LP$13.6bn113F-HR
Q4 2014Two Sigma Advisers LP$12.9bn113F-HR
Q3 2014Two Sigma Advisers LP$13.3bn113F-HR
Q2 2014Two Sigma Advisers LP$12.8bn113F-HR
Q1 2014Two Sigma Advisers LP$11.0bn13F-HR
Q4 2013Two Sigma Advisers LP$10.4bn13F-HR
Q3 2013Two Sigma Advisers LP$8.4bn13F-HR
Q2 2013Two Sigma Advisers LP$7.0bn13F-HR

Reading this record

A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More